RTC
GH icon

Riverview Trust Company’s Guardant Health GH Stock Holding History

Riverview Trust Company’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-443
Closed -$10.4K – 706
2023
Q1 		$10.4K Buy
+443
New +$12.7K 0.01% 667
2022
Q2 		– Sell
-220
Closed -$15K – 770
2022
Q1 		$15K Buy
+220
New +$15.1K 0.01% 610

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Riverview Trust Company's GH Position: Q2 2023 in Review

Riverview Trust Company sold out of Guardant Health (GH) in Q2 2023, closing a stake of 443 shares — an estimated $10.4K sold.

Riverview Trust Company first reported a position in GH in Q1 2022 and held it in 2 quarters. The position peaked at $15K in Q1 2022. 299 funds tracked by Wall St. Rank hold GH as of Q2 2023.

  • Riverview Trust Company reported no remaining Guardant Health position as of Q2 2023 after selling out during the quarter.
  • Riverview Trust Company sold 443 Guardant Health shares in Q2 2023, an estimated $10.4K.
  • Riverview Trust Company first reported a position in Guardant Health in Q1 2022 and held it in 2 quarters.
  • Riverview Trust Company's Guardant Health position peaked at $15K in Q1 2022.
  • 299 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Riverview Trust Company's 13F filing for Q2 2023, filed 18 Jul 2023.